Improved Sleep for Obesity and Diabetes Risk Reduction
EH
Overseen byErin Hanlon, Ph.D.
Age: 18 - 65
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: University of Chicago
No Placebo Group
Trial Summary
What is the purpose of this trial?
The goal of this study is to identify an intervention that improves sleep health and consequently metabolic health by examining whether sleep extension or enforced regularity in short sleepers will have beneficial effects on diabetes and obesity risk.
Research Team
EH
Erin Hanlon, Ph.D.
Principal Investigator
University of Chicago
Eligibility Criteria
This trial is for African American adults aged 21-50 who are overweight with a BMI of 25 to 30 and usually sleep less than 7 hours at night. Participants should have the potential to sleep more if they had the time.Inclusion Criteria
I am between 22 and 50 years old.
I usually sleep less than 7 hours a night.
I am African American.
See 1 more
Treatment Details
Interventions
- Sleep Extension (Behavioral Intervention)
- Sleep Regularity (Behavioral Intervention)
Trial OverviewThe study is testing two approaches to improve sleep health: one group will try sleeping longer (sleep extension), while another will focus on keeping a consistent sleep schedule (sleep regularity). The aim is to see if these methods can lower diabetes and obesity risk.
Participant Groups
2Treatment groups
Experimental Treatment
Group I: Sleep RegularityExperimental Treatment1 Intervention
Participants in the sleep regularity group will have consistent bedtimes (within 30min).
Group II: Sleep ExtensionExperimental Treatment1 Intervention
Participants that are in the sleep extension group will have their time in bed extended by 2 hours. This can include going to bed earlier and/or waking up later.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of Chicago
Lead Sponsor
Trials
1,086
Recruited
844,000+
Pete Salzmann
University of Chicago
Chief Executive Officer since 2018
MD from University of Chicago’s Pritzker School of Medicine, MBA from Stanford University’s Graduate School of Business
Anh Nguyen
University of Chicago
Chief Medical Officer
MD from Rutgers New Jersey Medical School, MBA from University of Chicago